Skip to content
Research Article Open access CC BY 4.0

Epidemiology, Evaluation and Management of Wilson Disease: Review Article

Mohammed Salah Hussein, Turki Mohammed A. Alshehri, Nada Muidh Aloufi, Alghamdi, Ibrahim Saeed A., Al zahrani, Adel Abdulrahman S., Fahad Ayed Alharbi, Ahmed Abdulaziz A. Alqerafi, Alsarraj, Nawaf Faiq M, Manal Abdulrahman Alem, Alotaibi. Saad Jamal

Journal of Pharmaceutical Research International · pp. 94–103 · Published 14 Dec 2021

10.9734/jpri/2021/v33i57A33973

Abstract

Wilson disease (hepatolenticular degeneration) is a rare autosomal recessive ailment characterized by aberrant copper buildup in the body, with the brain, liver, and cornea being notably affected. Wilson illness is caused by a mutation in the ATP7B gene on chromosome 13, which regulates the protein transporter that excretes excess copper into the bile and out of the body. So far, over 500 mutations have been discovered. The most common treatment for WD is D-penicillamine (D-PCA). Patients with severe spasms, deformities, or dysphonia, as well as those who are allergic to D-PCA, should avoid it. Early Diagnosis is a key factor in saving patient’s live, and thus prober investigation should be done as soon as possible.  Family screening is a must when a patient is diagnosed to role out any other patients in the family with the disease and because of the strong genetic factor impacting the disease. early detection is critical for initiating therapy in the early, asymptomatic stages of the disease, rather than when liver decompensation or extensive neurological irreversible harm has already occurred. In this circumstance, the optimum technique is to finish copper investigations in the index patient's first- and second-degree relatives. In the present article we’ll be discussing disease prevalence, etiology and more importantly diagnosis and management.

Wilson disease EPS D-penicillamine Wilson illness

References (32)

  1. 1 Wilson's disease and other neurological copper disorders [DOI]
  2. 2 Wilson disease [DOI]
  3. 3 Treatment of Wilson's disease with zinc: XV long-term follow-up studies [DOI]
  4. 4 Long-term Outcomes of Patients With Wilson Disease in a Large Austrian Cohort [DOI]
  5. 5 Wilson’s disease: A review of what we have learned [DOI]
  6. 6 Wilson's Disease: Clinical Practice Guidelines of the Indian National Association for Study of the Liver, the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition, and the Movement Disorders Society of India [DOI]
  7. 7 A Review and Current Perspective on Wilson Disease [DOI]
  8. 8 Epidemiology, diagnosis, and treatment of Wilson's disease [DOI]
  9. 9 Challenges in the diagnosis of Wilson disease [DOI]
  10. 10 Identification and Analysis of Mutations in the Wilson Disease Gene (ATP7B): Population Frequencies, Genotype-Phenotype Correlation, and Functional Analyses [DOI]
  11. 11 Prevention of Wilson's Disease in Asymptomatic Patients [DOI]
  12. 12 Wilson's disease: clinical presentation and use of prognostic index. [DOI]
  13. 13 Molecular characterization of Wilson disease in the Sardinian population?Evidence of a founder effect [DOI]
  14. 14 High prevalence of the H1069Q mutation in East German patients with Wilson disease: rapid detection of mutations by limited sequencing and phenotype–genotype analysis [DOI]
  15. 15 Haplotype and Mutation Analysis in Japanese Patients with Wilson Disease [DOI]
  16. 16 An epidemiological study of Wilson's disease in the Republic of Ireland. [DOI]
  17. 17 Mutation Analysis and the Correlation Between Genotype and Phenotype of Arg778Leu Mutation in Chinese Patients With Wilson Disease [DOI]
  18. 18 Mutation analysis of Wilson disease in the Spanish population - identification of a prevalent substitution and eight novel mutations in the ATP7B gene [DOI]
  19. 19 Epidemiology and introduction to the clinical presentation of Wilson disease [DOI]
  20. 20 Classification and differential diagnosis of Wilson’s disease [DOI]
  21. 21 The homozygosity index (HI) approach reveals high allele frequency for Wilson disease in the Sardinian population [DOI]
  22. 22 Prognostic Scoring Indices in Wilson Disease: A Case Series and Cautionary Tale [DOI]
  23. 23 Major Problems in Internal Medicine [DOI]
  24. 24 Epidemiologic study of hepatolenticular degeneration (Wilson's disease) in Sardinia (1902-1983) [DOI]
  25. 25 An assessment of efficiency in potential screening for Wilson's disease. [DOI]
  26. 26 High Incidence and Allelic Homogeneity of Wilson Disease in 2 Isolated Populations: A Prerequisite for Efficient Disease Prevention Programs [DOI]
  27. 27 Wilson's disease in Scotland. [DOI]
  28. 28 Wilson’s disease: Update on integrated Chinese and Western medicine [DOI]
  29. 29 Wilson disease in Iceland: a clinical and genetic study.
  30. 30 Therapeutic assessment of dimercaptosuccinic acid capsule in the treatment of hepatolenticular degeneration
  31. 31 Identification of three novel mutations and a high frequency of the Arg778Leu mutation in Korean patients with Wilson disease [DOI]
  32. 32 [The epidemiology of Wilson's disease in the German Democratic Republic and current problems from the viewpoint of population genetics].

Cited by 1

A grading method for Kayser Fleischer ring images based on ResNet

Wei Song, Ling Xin, Jie-Mei Wang · Heliyon · 2023

Related research

Article metrics

Real usage data collected on this platform.

21

Page views

0

PDF downloads

3

Outbound clicks

1

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.